Joseph Schwartz
Stock Analyst at Leerink Partners
(4.95)
# 146
Out of 5,090 analysts
1274
Total ratings
52.8%
Success rate
31.3%
Average return
Main Sectors:
Stocks Rated by Joseph Schwartz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WVE Wave Life Sciences | Rated: Buy | $25 → $10 | $3.59 | +178.55% | 32 | Oct 29, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Reiterated: Buy | $27.95 | $9.54 | +192.96% | 2 | Oct 1, 2026 | |
| IRLA IRulya Therapeutics | Reiterated: Buy | $68 | $32.95 | +106.37% | 1 | Sep 29, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $154 | $85.00 | +81.18% | 1 | Sep 28, 2026 | |
| EWTX Edgewise Therapeutics | Reiterated: Buy | n/a | $38.90 | - | 51 | Sep 23, 2026 | |
| ELOX Eloxx Pharmaceuticals | Initiated Coverage: Buy | $32 | $13.45 | +137.92% | 1 | Sep 18, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Buy | $33 | $16.10 | +104.97% | 71 | Sep 18, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $20 | $6.20 | +222.58% | 46 | Sep 16, 2026 | |
| PHVS Pharvaris | Rated: Buy | $38 → $65 | $33.53 | +93.86% | 38 | Sep 10, 2026 | |
| GOSS Gossamer Bio | Upgraded: Buy | $80 | $10.38 | +670.71% | 36 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $70 | $24.83 | +181.92% | 62 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $225 → $305 | $251.27 | +21.38% | 72 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $24 → $4 | $3.71 | +7.82% | 37 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $60 → $62 | $58.51 | +5.96% | 90 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1 → $9 | $4.53 | +98.68% | 23 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $8.27 | +202.30% | 1 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 → $120 | $46.39 | +158.68% | 32 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $31.48 | +58.83% | 9 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $18.62 | -19.44% | 107 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $50.39 | - | 87 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.66 | - | 50 | Dec 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $2 | $0.2895 | +590.85% | 31 | Dec 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $16 | $16.65 | -3.90% | 52 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $5 → $14 | $10.68 | +31.09% | 29 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $115 | $70.32 | +63.54% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $54 | $59.97 | n/a | 33 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $112.58 | n/a | 63 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $2.47 | n/a | 22 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.36 | n/a | 29 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.96 | n/a | 29 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $2.62 | n/a | 19 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $359.41 | n/a | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $150 → $30 | $6.49 | n/a | 10 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 → $34 | $43.52 | n/a | 3 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $144.85 | n/a | 28 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $466.01 | n/a | 1 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.71 | n/a | 1 | Jul 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $31 → $4 | $44.25 | n/a | 16 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $337.04 | n/a | 1 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53.43 | $256.84 | n/a | 1 | Apr 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $30 | $0.4955 | n/a | 2 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $37 → $23 | $12.47 | n/a | 2 | Nov 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $12 | $1.39 | n/a | 5 | Sep 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $121 → $126 | $598.72 | n/a | 4 | Apr 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.49 | n/a | 11 | Nov 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.0708 | n/a | 5 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $1.77 | n/a | 6 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $1.44 | n/a | 1 | Mar 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $664 | $927.89 | n/a | 7 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $512 → $425 | $253.62 | n/a | 3 | Sep 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 → $8 | $62.99 | n/a | 3 | May 19, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $12.11 | n/a | 6 | Oct 30, 2013 |
Wave Life Sciences
Oct 29, 2026
Rated: Buy
Price Target: $25 → $10
Current: $3.59
Upside: +178.55%
Satellos Bioscience Inc.
Oct 1, 2026
Reiterated: Buy
Price Target: $27.95
Current: $9.54
Upside: +192.96%
IRulya Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $68
Current: $32.95
Upside: +106.37%
Mirum Pharmaceuticals
Sep 28, 2026
Reiterated: Buy
Price Target: $154
Current: $85.00
Upside: +81.18%
Edgewise Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $38.90
Upside: -
Eloxx Pharmaceuticals
Sep 18, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $13.45
Upside: +137.92%
Ultragenyx Pharmaceutical
Sep 18, 2026
Reiterated: Buy
Price Target: $33
Current: $16.10
Upside: +104.97%
Solid Biosciences
Sep 16, 2026
Reiterated: Buy
Price Target: $20
Current: $6.20
Upside: +222.58%
Pharvaris
Sep 10, 2026
Rated: Buy
Price Target: $38 → $65
Current: $33.53
Upside: +93.86%
Gossamer Bio
Jul 27, 2026
Upgraded: Buy
Price Target: $80
Current: $10.38
Upside: +670.71%
Jun 17, 2026
Reiterated: Buy
Price Target: $60 → $70
Current: $24.83
Upside: +181.92%
Jun 2, 2026
Reiterated: Buy
Price Target: $225 → $305
Current: $251.27
Upside: +21.38%
Jun 2, 2026
Downgraded: Hold
Price Target: $24 → $4
Current: $3.71
Upside: +7.82%
May 18, 2026
Reiterated: Hold
Price Target: $60 → $62
Current: $58.51
Upside: +5.96%
May 15, 2026
Upgraded: Buy
Price Target: $1 → $9
Current: $4.53
Upside: +98.68%
May 15, 2026
Initiated Coverage: Buy
Price Target: $25
Current: $8.27
Upside: +202.30%
May 15, 2026
Reiterated: Buy
Price Target: $160 → $120
Current: $46.39
Upside: +158.68%
Mar 25, 2026
Reiterated: Buy
Price Target: $50
Current: $31.48
Upside: +58.83%
Mar 25, 2026
Reiterated: Hold
Price Target: $15
Current: $18.62
Upside: -19.44%
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $50.39
Upside: -
Dec 31, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.66
Upside: -
Dec 29, 2025
Reiterated: Buy
Price Target: $8 → $2
Current: $0.2895
Upside: +590.85%
Dec 3, 2025
Downgraded: Hold
Price Target: $12 → $16
Current: $16.65
Upside: -3.90%
Dec 3, 2025
Upgraded: Buy
Price Target: $5 → $14
Current: $10.68
Upside: +31.09%
Nov 10, 2025
Initiated Coverage: Buy
Price Target: $115
Current: $70.32
Upside: +63.54%
Oct 16, 2025
Reiterated: Hold
Price Target: $54
Current: $59.97
Upside: n/a
Sep 29, 2025
Reiterated: Buy
Price Target: n/a
Current: $112.58
Upside: n/a
Aug 15, 2025
Reiterated: Buy
Price Target: $25
Current: $2.47
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $10
Current: $2.36
Upside: n/a
Aug 12, 2024
Reiterated: Hold
Price Target: $1
Current: $0.96
Upside: n/a
May 7, 2024
Reiterated: Hold
Price Target: $10
Current: $2.62
Upside: n/a
Sep 7, 2023
Reiterated: Hold
Price Target: $14
Current: $359.41
Upside: n/a
Aug 18, 2023
Downgraded: Hold
Price Target: $150 → $30
Current: $6.49
Upside: n/a
Feb 3, 2023
Reiterated: Hold
Price Target: $40 → $34
Current: $43.52
Upside: n/a
Aug 5, 2022
Reiterated: Buy
Price Target: $30
Current: $144.85
Upside: n/a
Aug 4, 2022
Rated: Hold
Price Target: n/a
Current: $466.01
Upside: n/a
Jul 13, 2022
Reiterated: Buy
Price Target: n/a
Current: $10.71
Upside: n/a
Apr 5, 2022
Downgraded: Hold
Price Target: $31 → $4
Current: $44.25
Upside: n/a
May 7, 2021
Downgraded: Sell
Price Target: n/a
Current: $337.04
Upside: n/a
Apr 15, 2021
Reiterated: Buy
Price Target: $53.43
Current: $256.84
Upside: n/a
Jan 6, 2021
Downgraded: Hold
Price Target: $5 → $30
Current: $0.4955
Upside: n/a
Nov 28, 2018
Initiated Coverage: Buy
Price Target: $37 → $23
Current: $12.47
Upside: n/a
Sep 26, 2017
Reiterated: Buy
Price Target: $10 → $12
Current: $1.39
Upside: n/a
Apr 3, 2017
Reiterated: Hold
Price Target: $121 → $126
Current: $598.72
Upside: n/a
Nov 13, 2016
Reiterated: Buy
Price Target: n/a
Current: $9.49
Upside: n/a
Nov 10, 2016
Reiterated: Buy
Price Target: $8
Current: $0.0708
Upside: n/a
Nov 10, 2016
Reiterated: Buy
Price Target: $12 → $14
Current: $1.77
Upside: n/a
Mar 8, 2016
Reiterated: Buy
Price Target: $24
Current: $1.44
Upside: n/a
Oct 26, 2015
Reiterated: Buy
Price Target: $664
Current: $927.89
Upside: n/a
Sep 15, 2015
Reiterated: Buy
Price Target: $512 → $425
Current: $253.62
Upside: n/a
May 19, 2014
Initiated Coverage: Buy
Price Target: $20 → $8
Current: $62.99
Upside: n/a
Oct 30, 2013
Downgraded: Hold
Price Target: n/a
Current: $12.11
Upside: n/a